Business · 05/06/2006
FDA Releases Guidance for Industry on Antiviral Product Development
The Food and Drug Administration (FDA) has made available a guidance document to help pharmaceutical companies develop and submit crucial virology data for antiviral product trials, aiming to accelerate the development of new treatments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →